Correlation of steatosis severity (ultrasound grade) with liver fibrosis stage (shear wave elastography) in patients with non-alcoholic fatty liver disease
Keywords:
Non-Alcoholic Fatty Liver Disease, Ultrasound, Shear Wave Elastography, Liver Fibrosis, Fatty Liver GradingAbstract
Background and Aim: This study aimed to analyze the correlation between fatty liver grading based on ultrasonography and fibrosis staging using two-dimensional shear wave elastography (2D-SWE) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
Methods: A cross-sectional study was conducted in the Radiology Department of our hospital from July to October 2025. A total of 52 NAFLD patients who underwent conventional abdominal ultrasonography and 2D-SWE were included. Fatty liver grading was categorized into four groups (grade 0–3) based on echogenicity and visualization of intrahepatic vascular structures. Fibrosis staging was assessed using 2D-SWE according to the Metavir classification (F0–F4). Patient demographic characteristics were recorded from the electronic medical record (EMR). Statistical analyses included descriptive analysis, Chi-square tests to evaluate associations between categorical variables, and correlation analysis to assess the relationship between steatosis and fibrosis severity. Significance was defined as p < 0.05.
Results: Of the 52 patients, most were female (55.8%) and aged <46 years (57.7%). Grade 1 steatosis was the most common ultrasonography finding (71.2%), whereas F0–F1 fibrosis predominated on SWE (67.3%). No statistically significant association was observed between fatty liver grading and gender (p = 0.613) or age (p = 0.944). Similarly, fibrosis staging showed no association with gender (p = 0.371) or age (p = 0.687). However, a very strong positive correlation was found between ultrasonography-based steatosis grading and SWE-based fibrosis staging (p < 0.001, r = 0.875), indicating that increasing steatosis levels paralleled increasing fibrosis severity.
Conclusions: Fatty liver grading based on ultrasonography demonstrates a very strong correlation with fibrosis staging assessed by 2D-SWE, confirming the clinical relevance of combined ultrasound-based assessment in NAFLD imaging. While age and gender did not influence steatosis or fibrosis severity, direct fibrosis evaluation remains crucial for early risk stratification.
References
1. Pouwels S, Sakran N, Graham Y, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocrine Disorders. 2022;22(1):63. doi: 10.1186/s12902-022-00980-1
2. Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Translational Gastroenterology and Hepatology. 2020;5:16. doi: 10.21037/tgh.2019.09.08
3. Teng ML, Ng CH, Huang DQ, et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology. 2023;29(Suppl):S32-S42. doi: 10.3350/cmh.2022.0365
4. Anjani DAVN. Non-alcoholic fatty liver disease: diagnosis and treatment. Jurnal Biologi Tropis. 2023;23(3):213-24. doi: 10.29303/jbt.v23i3.5016
5. Petzold G. Role of ultrasound methods for the assessment of NAFLD. Journal of Clinical Medicine. 2022;11(15):4581. doi: 10.3390/jcm11154581
6. Lin Y, Feng X, Cao X, et al. Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes. Diabetology & Metabolic Syndrome. 2022;14(1):181. doi: 10.1186/s13098-022-00930-w
7. Dalbeni A, Castelli M, Zoncapè M, Minuz P, Sacerdoti D. Platelets in non-alcoholic fatty liver disease. Frontiers in Pharmacology. 2022;13:842636. doi: 10.3389/fphar.2022.842636
8. Ozturk A, Mohammadi R, Pierce TT, et al. Diagnostic accuracy of shear wave elastography as a non-invasive biomarker of high-risk non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease. Ultrasound in Medicine & Biology. 2020;46(4):972-80. doi: 10.1016/j.ultrasmedbio.2019.12.020
9. Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2022;7(9):851-61. doi: 10.1016/S2468-1253(22)00165-0
10. Balakrishnan M, Patel P, Dunn-Valadez S, et al. Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology. 2021;19(1):61-71.e15. doi: 10.1016/j.cgh.2020.04.067
11. Nagral A, Bangar M, Menezes S, et al. Gender Differences in Nonalcoholic Fatty Liver Disease. Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S19-S25. doi: 10.5005/jp-journals-10018-1370.
12. Lonardo A, Nascimbeni F, Ballestri S, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457-69. doi: 10.1002/hep.30626
13. Younossi ZM, Henry L. Fatty liver through the ages: nonalcoholic steatohepatitis. Endocrine Practice. 2022;28(2):204-13. doi: 10.1016/j.eprac.2021.12.010
14. Yoon JS, Lim KJ, Hwang IT. Usefulness of two-dimensional shear wave elastography in the assessment of non-alcoholic fatty liver disease in children and adolescents. Scientific Reports. 2023;13(1):10062. doi: 10.1038/s41598-023-37281-z
15. Huh Y, Cho YJ, Nam GE. Recent epidemiology and risk factors of nonalcoholic fatty liver disease. Journal of Obesity & Metabolic Syndrome. 2022;31(1):17-27. doi: 10.7570/jomes22021
16. Kim JW, Lee CH, Kim BH, et al. Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease. Quantitative Imaging in Medicine and Surgery. 2022;12(3):1815-29. doi: 10.21037/qims-21-895
17. Geethakumari P, Kampa P, Parchuri R, et al. Accuracy of ultrasonography vs. elastography in patients with non-alcoholic fatty liver disease: a systematic review. Cureus. 2022. doi: 10.7759/cureus.29967
18. Sharpton SR, Schnabl B, Knight R, Loomba R. Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease. Cell Metabolism. 2021;33(1):21-32. doi: 10.1016/j.cmet.2020.11.010
19. Jiang H, Qin C, Xu YM. Feasibility of shear wave elastography for assessing steatosis in early-stage non-alcoholic fatty liver disease. PLOS One. 2025;20(5):e0324637. doi: 10.1371/journal.pone.0324637
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Kurniati, Nikmatia Latief, Rafikah Rauf, Andi Alfian Zainuddin, Muhammad Luthfi Parewangi, Bachtiar Murtala
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
